Attention Deficit Hyperactivity Disorder: Genes, Cognition And Brain Activity
Funder
National Health and Medical Research Council
Funding Amount
$428,602.00
Summary
Attention deficit hyperactivity disorder (ADHD) is a common psychiatric disorder of childhood that is marked by age-inappropriate levels of inattention and-or hyperactivity-impulsivity. The disorder appears genetic with a number of different genes likely contributing risk for ADHD. I will use a multi-modal (genetic, cognitive, neurochemical, physiological) approach to increase our understanding of the biological mechanisms leading from gene to disorder in ADHD.
Solving The Jigsaw! Understanding Biological And Environmental Effects On ADHD Through Discordant Mononozygotic Twins
Funder
National Health and Medical Research Council
Funding Amount
$557,500.00
Summary
The recent Child and Adolescent component of the National Mental Health Survey identified Attention Deficit Hyperactivity Disorder(ADHD) as the most common behavioural problem among Australian children. Since 1991 our Australian Twin ADHD Project (ATAP) has developed as one of the world's largest programs on the genetics of ADHD, and in 2001 we published the first text on this topic. In this grant we turn the focus onto environmental influences with the question Why can one identical twin have A ....The recent Child and Adolescent component of the National Mental Health Survey identified Attention Deficit Hyperactivity Disorder(ADHD) as the most common behavioural problem among Australian children. Since 1991 our Australian Twin ADHD Project (ATAP) has developed as one of the world's largest programs on the genetics of ADHD, and in 2001 we published the first text on this topic. In this grant we turn the focus onto environmental influences with the question Why can one identical twin have ADHD, while the other twin has no difficulties? Using the unique resources of the Australian Twin Registry and the WA Twin Child Health Study, we shall work across the country to find over 100 identical twin pairs who are very different in ADHD. In this way, each ADHD affected twin has an unaffected 'control twin', offering a powerful means for comparing the two. Such a study is really only possible in Australia, as no other country has such twin resources for research. The questions we want to consider with these children include the following 1- Twins have a more difficult time before and at birth. To what extent do these problems contribute to differences between the twins? 2- Are there differences in specific aspects of brain functioning? 3- Is it that one twin grows out of their ADHD but the other does not? If so, what distinguishes the children? 4- What is it like growing up with a twin who has ADHD, when you have no difficulties yourself? 5- When one twin has ADHD symptoms, is the family more likely to seek help, as they can see how different this child is form the other twin? Obviously identical twins in wehich only one has ADHD are a very unique group. By covering all aspects of development, from brain functioning to service utilisation, the hope is that this study will provide invaluable insights into this common condition which will help all children and families where the diagnosis of ADHD has been made.Read moreRead less
Panic Disorder: Neurobiology And Mechanisms Of Cardiac Risks
Funder
National Health and Medical Research Council
Funding Amount
$414,375.00
Summary
Some people are subject to episodes of recurring, often inexplicable anxiety which are very unpleasant and accompanied by physical symptoms such as sweating, palpitations, tremor and a sensation of suffocation. Recurring attacks over a period of months, or years, forms the basis for the diagnosis of panic disorder. It has until recently been felt that although panic disorder was distressing and disabling, it did not constitute a risk to life. Sufferers often fear that they have heart disease, be ....Some people are subject to episodes of recurring, often inexplicable anxiety which are very unpleasant and accompanied by physical symptoms such as sweating, palpitations, tremor and a sensation of suffocation. Recurring attacks over a period of months, or years, forms the basis for the diagnosis of panic disorder. It has until recently been felt that although panic disorder was distressing and disabling, it did not constitute a risk to life. Sufferers often fear that they have heart disease, because of the nature of their symptoms, but have been reassured that this is not the case. Recent epidemiological studies, however, indicate that there is an increased risk of heart risk in patients with panic disorder. Our hypotheses in this research are as follows: That panic disorder is characterised by increased release of the brain chemical messenger, serotonin, which is reversed by drug treatment with the most widely used class of drugs for this disorder, selective serotonin reuptake blockers That changes in an automatic stimulatory part of the nervous system, has primary importance in the disorder, in both genetically predisposing to panic disorder, and in mediating heart risk. That weight gain during therapy, a very common problem, is due to inhibition of brain serotonin release. We will test all these propositions using state of the art clinical scientific methods. Panic disorder has an important cardiological dimension which needs to be better understood for cardiac protection to be achieved in panic disorder patients. Our study of the mechanisms of cardiac risk should provide this. We will also provide very direct, valid measurements of chemical messenger release in the brain of panic disorder sufferers, using our unique methods. These should give a new understanding of the brain chemistry abnormalities of panic disorder, and the mechanism of action of the selective serotonin reuptake inhibitors.Read moreRead less